Evidence map›Paper›PMID 41282156›Full record

ArticleResearch square2025

Multimodal biological profiles of symptom-based subgroups in recent-onset psychosis.

Nicholaos Koutsouleris, Madalina O Buciuman, Clara Vetter, Ananda Bajrić, Clara Weyer, Santiago Tovar Perdomo, Adyasha Tejaswi Khuntia, Yuri Milaneschi, David Popovic, Dominic Dwyer and 19 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Nicholaos KoutsoulerisLudwig Maximillian University.ORCID https://orcid.org/0000-0001-6825-6262
Madalina O BuciumanDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich.
Clara VetterDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich.
Ananda BajrićMax Planck School of Cognition, Leipzig.
Clara WeyerDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich.
Santiago Tovar PerdomoDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich.
Adyasha Tejaswi KhuntiaLudwig-Maximilian-University.ORCID https://orcid.org/0009-0007-9297-5997
Yuri MilaneschiAmsterdam UMC, Vrije Universiteit/GGZ inGeest.ORCID https://orcid.org/0000-0002-3697-6617
David PopovicMax Planck Institute of Psychiatry.ORCID https://orcid.org/0000-0002-2367-9437
Dominic DwyerCentre for Youth Mental Health, University of Melbourne.
Katharine ChisholmSchool of Psychology, University of Sussex.
Lana Kambeitz-IlankovicDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne.
Linda AntonucciDepartment of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro.
Theresa LichtensteinDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne.
Marlene RosenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne.
Stephan RuhrmannUniversity of Cologne, Faculty of Medicine and University Hospital.ORCID https://orcid.org/0000-0002-6022-2364
Joseph KambeitzFaculty of Medicine and University Hospital University of Cologne, Cologne.ORCID https://orcid.org/0000-0002-8988-3959
Anita Riecher-RösslerMedical Faculty, University of Basel.ORCID https://orcid.org/0000-0001-6361-8789
Rachel UpthegroveUniversity of Oxford.ORCID https://orcid.org/0000-0001-8204-5103
Raimo SalokangasDepartment of Psychiatry, University of Turku.
Jarmo HietalaUniversity of Turku.ORCID https://orcid.org/0000-0002-3179-6780
Christos PantelisUniversity of Melbourne.ORCID https://orcid.org/0000-0002-9565-0238
Rebekka LencerDepartment of Psychiatry and Psychotherapy, University of Münster.
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University.
Stephen WoodUniversity of Melbourne.ORCID https://orcid.org/0000-0003-4186-5919
Paolo BrambillaUniversity of Milan.
Stefan BorgwardtUniversity of Lübeck.ORCID https://orcid.org/0000-0002-5792-3987
Alessandro BertolinoDepartment of Translational Biomedicine and Neuroscience, University of Bari "Aldo Moro", Bari, Italy.
Peter FalkaiLudwig Maximilians University Munich.

Funding

ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2M
NIMH NIH HHS U01 MH124639Wellcome Trust
6 · The paper itself

Abstract

Symptom diversity in psychoses complicates the search for biological markers. Using Positive and Negative Symptom Scale data from 362 recent-onset patients in the multicenter PRONIA study, we identified four subgroups with dominant symptom patterns: motor/cognitive, positive, social withdrawal, and affective. Subgroups were compared against each other and to 338 healthy controls across neurocognition, brain imaging, and genetic risk. Patient subgroups shared a profile of impaired processing speed and altered functional connectivity, with increased coupling in sensorimotor networks and reduced connectivity within and between default-mode, salience, and control networks. Variations in modality-specific neurobiological underpinnings differentiated subgroups, with fronto-temporal gray-matter loss characterizing the motor/cognitive and positive subgroups, and elevated genetic risk best separating the positive subgroup from the rest. The motor/cognitive group showed the most severe alterations across modalities, reaching the highest multimodal separability from controls (Balanced Accuracy=82.1%, sensitivity=74.9%, specificity=89.3%). Our findings support a framework of shared biological dysfunction with modality-selective vulnerabilities shaping symptom heterogeneity in early-stage psychotic disorders.

Indexed as

early psychosisfactor analysisneurocognitionneuroimagingpolygenic risk scoresubtyping

Identifiers

PMID41282156
PMCPMC12636741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.